Awards validate strategic focus on premium,
indoor-grown cannabis.
MONCTON, NB, Dec. 4, 2017 /CNW/ - On November 30, members of Canada's cannabis industry gathered for the
fourth annual Canadian Cannabis Awards ceremony and gala, an event
designed to recognize exceptional quality, forward-thinking
innovation and superior service in the cannabis space.
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the
"Company" or "Organigram"), a leading licensed producer of medical
marijuana based in Moncton, New
Brunswick, is proud to have been honoured with one of the
most coveted awards of the evening: Top Sativa Flower for its
popular premium flower, Wabanaki.
"We're thrilled to have been recognized for our product
quality," says Organigram CEO Greg
Engel. "These awards are chosen by people who know Canadian
cannabis and know it very, very well. To have been selected from a
deep pool of competing products in the medical marketplace speaks
to the hard work and dedication of our team, who don't compromise
in their efforts to produce exceptional products for our
patients."
Organigram was also awarded the Top Blended/Value Variety
distinction for its indica-dominant Blueberry Cheesecake Premium
Blend and as the Top Licensed Producer for Compassionate Pricing.
Organigram was also nominated in the Top Licensed Producer Customer
Service category.
"Our showing at this year's Lift Canadian Cannabis Awards is
only the beginning," added Engel. "These awards are another
validation that Organigram is well positioned with high quality
products for the anticipated premium adult-use recreational flower
market. Management believes our focus on quality indoor-grown
product will ultimately deliver long term shareholder value."
Further, the province of New
Brunswick was chosen as Most Progressive Public Office.
Headquartered in Moncton, New
Brunswick, Organigram has worked closely with the province
by providing input and support that the Company feels will,
ultimately, lead to a cannabis marketplace that's enviable,
vibrant, safe and sustainable. Earlier this year, the company
signed a memorandum of understanding with the Crown corporation
responsible for overseeing the anticipated adult-use recreational
marketplace in New Brunswick for a
minimum of 5,000kg of product per year.
The awards are organized and hosted by Lift, a common ground for
patients, producers and industry personnel to share reviews, gather
and network. Voter-driven categories for the Lift Canadian Cannabis
Awards were open through the month of September, and finalists were
announced in October 2017.
A full list of award recipients from the fourth annual Lift
Canadian Cannabis Awards ceremony is available here:
https://canadiancannabisawards.com/winners/cca2017/
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of medical marijuana in Canada. Organigram is focused on producing the
highest quality, condition specific medical marijuana for patients
in Canada. Organigram's facility
is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Organigram has been ranked in the top ten Clean Technology
& Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors, including but not limited to the
availability of funds, the results of financing efforts, the
consummation of definitive documentation in respect of the
memorandum of understanding, the Company's ability to execute on
its expansion plans and the Company's crop yields, that could cause
actual results to differ materially from the Company's expectations
are disclosed in the Company's documents filed from time to time on
SEDAR (see www.sedar.com). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. The Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
For more information, visit www.Organigram.ca
SOURCE OrganiGram